Please find attached unaudited financial results for the quarter and half-year ended 30 September 2025 and limited review report. The Auditors have provided an unmodified report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunshield Chemicals' board approved its unaudited results for the quarter and half-year ended September 30, 2025, with auditors CNK & Associates LLP issuing an unmodified (clean) limited review report. Revenue from operations for H1 FY26 rose to Rs. 23,628 lakhs from Rs. 17,087 lakhs in H1 FY25, a growth of about 38%. Standalone profit after tax nearly doubled to Rs. 1,405 lakhs (vs Rs. 720 lakhs), with EPS at Rs. 19.11 (vs Rs. 9.79). Q2 alone saw revenue of Rs. 12,240 lakhs (vs Rs. 9,291 lakhs) and PAT of Rs. 723 lakhs (vs Rs. 319 lakhs), also showing strong YoY growth. The company operates in a single segment, Speciality Chemicals. During the period, the company also completed a Rights Issue of 14,41,776 shares at Rs. 901 per share, allotted on October 27, 2025.
A clean audit report combined with sharply higher revenue and profits is a positive signal for shareholders. However, the recently completed Rights Issue means existing shareholders now hold a diluted stake, and equity base has been expanded — investors should factor this into per-share comparisons going forward.